TNXP (STOCKS)
Tonix Pharmaceuticals Holding Corp.
$12.640000
+0.670000 (+5.60%)
Prev close: $11.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Seth Lederman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $240.80M
- Employees
- 81
- P/E (TTM)
- -0.93
- P/B (TTM)
- 0.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-2.44 | $-2.75 | +0.3106 | +11.29% |
|
Mar 2026 (Q1)
|
$-2.93 | $-2.48 | -0.4480 | -18.05% |
|
Dec 2025 (Q4)
|
$-3.98 | $-3.25 | -0.7262 | -22.32% |
|
Sep 2025 (Q3)
|
$-3.59 | $-3.66 | +0.0667 | +1.82% |
Financial Statements
| Revenues | $29.10M |
| Benefits Costs and Expenses | $194.53M |
| Cost Of Revenue | $4.71M |
| Costs And Expenses | $194.53M |
| Gross Profit | $24.40M |
| Operating Expenses | $189.82M |
| Selling, General, and Administrative Expenses | $125.96M |
| Depreciation and Amortization | $2.10M |
| Research and Development | $63.86M |
| Operating Income/Loss | -$165.43M |
| Income/Loss From Continuing Operations After Tax | -$159.67M |
| Income/Loss From Continuing Operations Before Tax | -$165.43M |
| Net Income/Loss | -$159.67M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$159.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$159.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$13.11 |
| Diluted Earnings Per Share | -$13.11 |
| Basic Average Shares | 40,373,068 |
| Diluted Average Shares | 40,373,068 |
| Assets | $254.09M |
| Current Assets | $203.43M |
| Noncurrent Assets | $50.66M |
| Fixed Assets | $44.76M |
| Other Non-current Assets | $5.90M |
| Liabilities | $31.81M |
| Current Liabilities | $30.79M |
| Accounts Payable | $9.05M |
| Other Current Liabilities | $21.73M |
| Noncurrent Liabilities | $1.02M |
| Equity | $222.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $222.28M |
| Liabilities And Equity | $254.09M |
| Net Cash Flow From Operating Activities | -$152.99M |
| Net Cash Flow From Operating Activities, Continuing | -$152.99M |
| Net Cash Flow From Investing Activities | -$4.26M |
| Net Cash Flow From Investing Activities, Continuing | -$4.26M |
| Net Cash Flow From Financing Activities | $207.71M |
| Net Cash Flow From Financing Activities, Continuing | $207.71M |
| Exchange Gains/Losses | -$76.00K |
| Net Cash Flow | $50.38M |
| Net Cash Flow, Continuing | $50.46M |
| Comprehensive Income/Loss | -$159.75M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$159.74M |
| Other Comprehensive Income/Loss | -$119.56M |